Showing results (161-170 of 1,071) with videos related to

Sort By:
Pageof 108
British Journal of Biomedical Science|September 18, 2020
Understanding the dynamics of COVID-19; implications for therapeutic intervention, vaccine development and movement controlS Salvamani, H Z Tan, W J Thang, et al.
British Journal of Biomedical Science|October 4, 2005
Differential growth of epidemic methicillin-resistant Staphylococcus aureus in vancomycinI Alshami, R C Matthews, J F Burnie, et al.
British Journal of Biomedical Science|October 4, 2005
Lack of association of CCR gene polymorphisms and left ventricular hypertrophy in essential hypertensionM Mettimano, M L Specchia, G La Torre, et al.
British Journal of Biomedical Science|April 15, 2006
Stimulatory effects of Antidesma madagascariense on D-glucose, L-tyrosine, fluid and electrolyte transport across rat everted intestine, comparable to insulin action in vitroM F Mahomoodally, A Gurib Fakim, A H Subratty
British Journal of Biomedical Science|July 7, 2005
Altered lipid parameters in patients infected with Entamoeba histolytica, Entamoeba dispar and Giardia lambliaD Bansal, H S Bhatti, R Sehgal
British Journal of Biomedical Science|July 7, 2005
Prevalence of Fusobacterium necrophorum and other upper respiratory tract pathogens isolated from throat swabsA Batty, M W D Wren
British Journal of Biomedical Science|July 7, 2005
Hepatitis C antibodies in asymptomatic first-time blood donors in The Gambia: prevalence and risk factorsC I Mboto, A Davies-Russell, M Fielder, et al.
British Journal of Biomedical Science|April 9, 2005
Infections with Corynebacterium diphtheriae: six years' experience at an inner London teaching hospitalM W D Wren, N Shetty
British Journal of Biomedical Science|April 9, 2005
Evaluation of a distance-learning immunology and pathology module in a postgraduate biomedical science courseM T Ryan, C W Mulholland
British Journal of Biomedical Science|April 9, 2005
Low frequency of elevated prothrombin times in patients with lupus anticoagulants when using a recombinant thromboplastin reagent: implications for dosing and monitoring of oral anticoagulant therapyG W Moore, S Rangarajan, L J Holland, et al.
Pageof 108